Cargando…

“Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital”

Detalles Bibliográficos
Autores principales:	Barthwal, M. S., Ramesh, Ashwin CB, Sahasrabudhe, Tushar, Dole, Sachinkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298816/ https://www.ncbi.nlm.nih.gov/pubmed/37148037 http://dx.doi.org/10.4103/lungindia.lungindia_540_22

Ejemplares similares

Management of COVID-19: A comprehensive and practical approach
por: Barthwal, M.S., et al.
Publicado: (2023)

Medical thoracoscopic cryoevacuation: A novel technique to manage retained hemothorax
por: Barthwal, Madhu Sudan, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Efficacy of tocilizumab in treatment of COVID-19 pneumonia: A case–control study from a tertiary care hospital
por: Shastri, Minal, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019
por: Mombrun, Martin, et al.
Publicado: (2021)

Medical retina hotline: Service evaluation and assessment of efficacy of a novel system in a tertiary care hospital
por: Agarwal, Aditi Ashok Kumar, et al.
Publicado: (2021)

Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy
por: Ammirati, Enrico, et al.
Publicado: (2020)

Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis
por: Leclercq, Mathilde, et al.
Publicado: (2023)

Clinicopathological Study of Glomus Tumors in a Tertiary Care Hospital
por: Kumararaja, Poornima, et al.
Publicado: (2022)

PATTERN OF PSORIASIS IN A TERTIARY CARE TEACHING HOSPITAL IN SOUTH INDIA
por: Asokan, N, et al.
Publicado: (2011)

Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya
por: Shah, Reena, et al.
Publicado: (2022)

Commentary on “Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India”
por: Rahemtoola, Muhammad Shariq, et al.
Publicado: (2021)

Successful treatment of a critical COVID-19 patient with tocilizumab
por: Tsao, Shih-Ming, et al.
Publicado: (2021)

Current status of leprosy as seen in a tertiary care hospital in north India
por: Jain, Amita
Publicado: (2012)

Revisiting tuberculids – Five year experience in a tertiary care teaching hospital
por: Panda, Maitreyee, et al.
Publicado: (2016)

Tocilizumab in COVID-19: finding the optimal route and dose
por: Jain, Siddharth, et al.
Publicado: (2020)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Yang, Chengliang, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Neumann, Avidan U, et al.
Publicado: (2021)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
por: Salama, Carlos, et al.
Publicado: (2020)

Infection prevention and control practices for emergency surgery during the COVID-19 pandemic in a tertiary care hospital in South Korea
por: Kim, Si-Hyun, et al.
Publicado: (2021)

Clinicomycological Study of 150 Cases of Dermatophytosis in a Tertiary Care Hospital in South India
por: Hanumanthappa, H, et al.
Publicado: (2012)

An intervention to evaluate & improve handling of cancer drugs in a tertiary care hospital in India
por: Kiran, D V R, et al.
Publicado: (2017)

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
por: Agirbasli, Mehmet, et al.
Publicado: (2021)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
por: Chuang, Tzu-Yi, et al.
Publicado: (2021)

Necrotizing fasciitis with slow progression in a patient with rheumatoid arthritis receiving tocilizumab
por: Goto, Kazuya, et al.
Publicado: (2022)

Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma
por: Eberst, Lauriane, et al.
Publicado: (2020)

First, Do No Harm: Caution Against Use of Tocilizumab in COVID-19
por: Mastroianni, Fiore
Publicado: (2020)

Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply
por: Horby, Peter, et al.
Publicado: (2021)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

Safety and Efficacy of Tocilizumab in the Treatment of Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia: A Retrospective Cohort Study
por: Patel, Atul, et al.
Publicado: (2020)

Multi-drug resistance in clinical isolates of Gram-negative bacilli in a tertiary care hospital of Assam
por: Dutta, Himadri, et al.
Publicado: (2014)

Rapid detection of Brucella by an automated blood culture system at a tertiary care hospital of north India
por: Raj, Atul, et al.
Publicado: (2014)

Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India
por: Shah, Viral N.
Publicado: (2014)

Prevalence of antidepressant-induced sexual dysfunction among psychiatric outpatients attending a tertiary care hospital
por: Al-Nimer, Marwan S., et al.
Publicado: (2020)

A study on surgical site infections after trauma surgeries in a tertiary care hospital in north India
por: Rajkumari, Nonika, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_964l2ieqaoqm1r86sb59t6eeoh